The Cigna Group (NYSE:CI) Shares Sold by D.A. Davidson & CO.

D.A. Davidson & CO. decreased its holdings in shares of The Cigna Group (NYSE:CI) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,443 shares of the health services provider’s stock after selling 546 shares during the quarter. D.A. Davidson & CO.’s holdings in The Cigna Group were worth $4,817,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Adero Partners LLC boosted its holdings in shares of The Cigna Group by 4.5% during the third quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock worth $273,000 after purchasing an additional 34 shares during the last quarter. CreativeOne Wealth LLC boosted its holdings in The Cigna Group by 3.0% in the third quarter. CreativeOne Wealth LLC now owns 1,219 shares of the health services provider’s stock valued at $422,000 after acquiring an additional 35 shares during the last quarter. Smithfield Trust Co boosted its holdings in The Cigna Group by 3.6% in the third quarter. Smithfield Trust Co now owns 1,080 shares of the health services provider’s stock valued at $373,000 after acquiring an additional 38 shares during the last quarter. Griffin Asset Management Inc. boosted its holdings in The Cigna Group by 0.6% in the fourth quarter. Griffin Asset Management Inc. now owns 6,770 shares of the health services provider’s stock valued at $1,869,000 after acquiring an additional 39 shares during the last quarter. Finally, Deseret Mutual Benefit Administrators boosted its holdings in The Cigna Group by 5.6% in the third quarter. Deseret Mutual Benefit Administrators now owns 751 shares of the health services provider’s stock valued at $260,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Up 0.9 %

Shares of NYSE CI opened at $297.27 on Thursday. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The firm has a market cap of $82.69 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 0.96 and a beta of 0.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The stock’s 50-day simple moving average is $285.65 and its 200-day simple moving average is $319.92.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the business earned $6.79 EPS. As a group, equities analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be issued a $1.51 dividend. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.03%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s payout ratio is currently 49.35%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on CI shares. Barclays reduced their target price on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Morgan Stanley reduced their target price on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Truist Financial reduced their target price on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a report on Tuesday, February 4th. Oppenheimer reduced their target price on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a report on Friday, January 31st. Finally, Royal Bank of Canada cut their price objective on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $373.69.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.